Start Date
Immediate
Expiry Date
03 Aug, 25
Salary
0.0
Posted On
04 May, 25
Experience
0 year(s) or above
Remote Job
Yes
Telecommute
Yes
Sponsor Visa
No
Skills
Infectious Diseases, Molecular Microbiology, Genomics, Cell Biology, Immunology, Bioinformatics, Research, Infection
Industry
Education Management
The Division of Infectious Diseases is actively recruiting an Assistant Professor (Research Track) with expertise in the area of M. tuberculosis and/or other pathogens of public health significance. A successful candidate is expected to have expertise in the field of tuberculosis (TB) as proved by their publication track record. Applicants with scientific background in microbiology and infectious diseases, specifically in the fields of cell and molecular biology, microbial genomics and transcriptomics, and Next Generation Sequencing (NGS) will be preferable, as well as with expertise in the fields of lung biology and aging. Preferable applicants will have research focus on determining the transcriptomic and metabolic changes occurring during the initial stages of Mycobacterium tuberculosis infection defining bacterial and host determinants as potential targets to develop new therapeutic/vaccine strategies. Preferable applicants will have expertise in all aspects of the human model of M. tuberculosis infection, including cell biology, molecular biology, and immunology. Applicants must be qualified to work in a Biosafety Level 3 (BSL-3) environment, and be accredited to work with drug-resistant M. tuberculosis strains, including multi- (MDR), pre-extensive- (pre-XDR) and extensive- (XDR) drug-resistant clinical isolates.
The Ohio State University College of Medicine and the Wexner Medical Center seek an Associate Professor (Research Track) to join the Department of Internal Medicine Academic rank and track commensurate with academic record and experience.
POSITION OVERVIEW
The Division of Infectious Diseases is actively recruiting an Assistant Professor (Research Track) with expertise in the area of M. tuberculosis and/or other pathogens of public health significance. A successful candidate is expected to have expertise in the field of tuberculosis (TB) as proved by their publication track record. Applicants with scientific background in microbiology and infectious diseases, specifically in the fields of cell and molecular biology, microbial genomics and transcriptomics, and Next Generation Sequencing (NGS) will be preferable, as well as with expertise in the fields of lung biology and aging. Preferable applicants will have research focus on determining the transcriptomic and metabolic changes occurring during the initial stages of Mycobacterium tuberculosis infection defining bacterial and host determinants as potential targets to develop new therapeutic/vaccine strategies. Preferable applicants will have expertise in all aspects of the human model of M. tuberculosis infection, including cell biology, molecular biology, and immunology. Applicants must be qualified to work in a Biosafety Level 3 (BSL-3) environment, and be accredited to work with drug-resistant M. tuberculosis strains, including multi- (MDR), pre-extensive- (pre-XDR) and extensive- (XDR) drug-resistant clinical isolates.
REQUIREMENTS